Cotrimoxazole Prophylaxis in Severely Malnourished Children

PHASE3CompletedINTERVENTIONAL
Enrollment

1,781

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Nutrition DisordersLife-threatening Infection
Interventions
DRUG

Cotrimoxazole dispersible tablet

Cotrimoxazole dispersible tablets 120/240mg daily for six consecutive months.

DRUG

Placebo dispersible tablet

Placebo dispersible tablets 120/240mg daily for six consecutive months.

Trial Locations (4)

80108

KEMRI/Wellcome Trust Research Programme, Kilifi

Unknown

Malindi District Hospital, Malindi

Coast Provincial General Hospital, Mombasa

Mbagathi District Hospital, Nairobi

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

lead

University of Oxford

OTHER